Zion Market Research has published a new report titled “Antihypertensives Market by Drug Class (Vasodilators, Renin inhibitors, Calcium channel blockers, Alpha blockers, Beta blockers, Angiotensin converting enzyme (ACE) inhibitors, Angiotensin receptor blockers (ARBs), Diuretics and Other Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for antihypertensives market was valued at approximately USD 26.18 billion in 2018, and is expected to generate revenue of around USD 30.62 billion by end of 2025, growing at a CAGR of around 2.3% between 2019 and 2025.
Hypertension is a long term medical condition commonly called as high blood pressure (HBP). The blood pressure in arteries is elevated persistently. Hypertension may be of two types, primary or essential hypertension which is due to unhealthy lifestyle or genetic factors. The secondary hypertension is due to an endocrine disorder, narrowing of the kidney arteries, chronic kidney disease, or due to use of birth control pills. Antihypertensives are prescribed to keep the hypertension in control and avoid hypertension related complications such as stroke, myocardial infarction, dementia, heart failure etc. Large numbers of antihypertensives are used to control elevated blood pressure such as diuretics, renin inhibitors, vasodilators, alpha blockers, calcium channel blockers, beta blockers, angiotensin receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors and others.
Request For Free Sample Report @ https://www.zionmarketresearch.com/sample/antihypertensives-market
The global antihypertensives market growth is supported by various factors such as increasing occurrence of hypertension among adults, excessive consumption of salt, lack of physical activity, sedentary lifestyle, obesity, smoking and changing eating habits and increasing prevalence of cardiovascular disease across the globe. Additionally, rising elderly population, increasing health awareness, increasing disposable income and health spending are other factors that fuel the market growth. Availability of large number of generics and increasing competition among established market players may act as a restraint to the market growth. Launch of novel therapies and emerging nations with increasing elderly population are expected to bring new growth avenues for major market players operating in the global antihypertensives.
The study offers a decisive view on the antihypertensives by segmenting the market based on drug class and region. Based on drug class, global antihypertensives market is categorized into vasodilators, calcium channel blockers, alpha blockers, diuretics, renin inhibitors, beta blockers, angiotensin receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors and other drugs. Market was dominated by diuretics drug class segment in 2018 as diuretics are considered as first line of treatment in blood pressure management. Calcium channel blockers and beta blockers will register rapid growth over the forecast period.
At region level, North America dominated the global antihypertensives market in 2018. Growth in this region is supported by multiple factors such as rising prevalence of hypertension, growing health awareness, increasing risk of hypertension associated cardiovascular complications such as heart failure, stroke, ischemic heart disease etc., and emphasis of major players to unveil novel therapies with lower side effects and higher efficiency. Europe was second largest regional market. Favorable reimbursement policies, increasing aging population, increasing prevalence of hypertension and health awareness are some of factors that fuel market growth in this region. Latin America is estimated to witness moderate growth over the forecast period. Asia Pacific region will register highest growth for antihypertensives market in the coming years. Increasing aging population, rising prevalence of hypertension and related complications due to changing eating habits, sedentary lifestyle, lack of physical activity, smoking, obesity are factors propelling antihypertensives market growth in Asia Pacific. Middle East and Africa will see moderate growth in coming years.
Major players included in the report are Johnson & Johnson Ltd., AstraZeneca Plc, Boehringer Ingelheim, Lupin Limited, Sanofi S.A., Merck & Co., Pfizer Inc., Novartis AG and Daiichi Sankyo Company Limited among others.
The report segment of global antihypertensives market as follows:
Global Antihypertensives Market: By Drug Class
Global Antihypertensives Market: By Region
Inquire more before buying this report @ https://www.zionmarketresearch.com/inquiry/antihypertensives-market